|
|
|
Volumn 31, Issue 1, 1996, Pages 99-106
|
|
Maintenance strategies in Crohn's disease
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINOSALICYLIC ACID DERIVATIVE;
ANTIBIOTIC AGENT;
ANTIINFLAMMATORY AGENT;
ANTIMETABOLITE;
AZATHIOPRINE;
BUDESONIDE;
CORTICOSTEROID;
CYCLOSPORIN;
CYTOKINE;
ENEMA;
ETHYL CELLULOSE;
IMMUNOMODULATING AGENT;
INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
INTERLEUKIN 10;
INTERLEUKIN 11;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
METRONIDAZOLE;
OKT 4;
OLSALAZINE;
POLYACRYLIC ACID;
SALAZOSULFAPYRIDINE;
SULFAPYRIDINE;
TUMOR NECROSIS FACTOR ANTIBODY;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DIFFERENTIAL DIAGNOSIS;
DOSE RESPONSE;
DRUG CAPSULE;
DRUG COATING;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG METABOLISM;
HUMAN;
MAINTENANCE THERAPY;
ORAL DRUG ADMINISTRATION;
PATHOGENESIS;
PHARMACEUTICS;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
REVIEW;
SUPPOSITORY;
TOPICAL DRUG ADMINISTRATION;
ULCERATIVE COLITIS;
AMINOSALICYLIC ACIDS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
COLITIS, ULCERATIVE;
COMBINED MODALITY THERAPY;
CROHN DISEASE;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
HUMANS;
MALE;
MESALAMINE;
POSTOPERATIVE CARE;
REMISSION INDUCTION;
SULFASALAZINE;
|
|
EID: 0030040297
PISSN: 87502836
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (8)
|
